000 01501 a2200445 4500
005 20250511204642.0
264 0 _c19920417
008 199204s 0 0 eng d
022 _a0959-8049
024 7 _a10.1016/0277-5379(91)90564-t
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aArcese, W
245 0 0 _aInterferon therapy for Ph1-positive chronic myelogenous leukaemia patients relapsing after T-cell depleted allogeneic bone marrow transplantation.
_h[electronic resource]
260 _bEuropean journal of cancer (Oxford, England : 1990)
_c1991
300 _aS28-30 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aBone Marrow Transplantation
650 0 4 _aChild
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInterferon alpha-2
650 0 4 _aInterferon-alpha
_xtherapeutic use
650 0 4 _aLeukemia, Myelogenous, Chronic, BCR-ABL Positive
_xmortality
650 0 4 _aMale
650 0 4 _aPhiladelphia Chromosome
650 0 4 _aRecombinant Proteins
700 1 _aMauro, F R
700 1 _aScrenci, M
700 1 _aAlimena, G
700 1 _aLo Coco, F
700 1 _aIori, A P
700 1 _ade Cuia, M R
700 1 _aFazi, P
700 1 _aMontefusco, E
700 1 _aMandelli, F
773 0 _tEuropean journal of cancer (Oxford, England : 1990)
_gvol. 27 Suppl 4
_gp. S28-30
856 4 0 _uhttps://doi.org/10.1016/0277-5379(91)90564-t
_zAvailable from publisher's website
999 _c1805695
_d1805695